Organon shares jump as Merck's new women's health spinoff posts strong start for biosims, infertility drugs

Organon shares jump as Merck's new women's health spinoff posts strong start for biosims, infertility drugs

Source: 
Fierce Pharma
snippet: 

It’s been a mere two months since Merck’s women’s health spinoff Organon set off to chart its own path as an independent company. That hasn’t been an easy feat amid a global pandemic, but so far the fledgling drugmaker is delivering early results that are catching Wall Street’s attention.